Afrezzauser's comments, assuming true, is great news considering that millions upon millions of diabetics can, hopefully, one day feel as confident in controlling their diabetes with AFrezza. Unfortunately, MNKD actually has to get the drug and device approved. By switching inhalers, MNKD has suffered a two year delay and ~200 million dollars more in costs. All of the wonders of this device and technoshpere insulin means nothing if MNKD can't get approval or can't find a way to fund themselves prior up to and beyond approval.